OVID

Conviction 55HealthcareScan · Fri, Jun 26, 2026

Bullish engulfing

OVID$2.54+4.96%

ResistanceSupportVol 14

Vol MA14 4M

Mar 27Apr 15May 4May 20Jun 9Jun 26

Ovid Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.ovidrx.com ↗

Price2.54

Change+4.96%

Gap-0.83%

Rel volume4.79×

Avg volume3.3M

Avg $ vol7.87M

SMA 202.39

SMA 502.57

SMA 2001.91

Price vs 50-1.24%

Price vs 200+33.07%

MA stackmixed

50/200 cross—

Supertrenddown · 2.76

RSI (14)55

MACD hist0.03

MACD crossbull · 2d

Stoch %K / %D86 / 82

ADX (14)17

+DI / −DI20 / 16

RSI divergence—

MACD divergence—

ATR %+6.83%

ADR %7.25%

52w high2.96

52w low0.3020

From 52w high-14.19%

Above 52w low+741.06%

New 52w highNo

SqueezeOff

Bollinger width20.47%

%B0.80

Donchian pos62.17%

Donchian high2.77

Donchian low2.16

AVWAP (52w high)2.60

vs AVWAP high-2.36%

AVWAP (52w low)1.83

vs AVWAP low+38.88%

OBV trendFlat

Chaikin MF (20)-0.17

Today vs 20d4.79×

Avg vol (14d)4M

Avg vol (20d)3.3M

Avg $ vol (20d)7.87M

Market cap—

RS 3m (vs SPY)-10.96%

RS 6m (vs SPY)+27.97%

RS line new highNo

Trend template6/8

Technical rank71.9

1 week+11.89%

1 month+0.00%

3 months+3.25%

6 months+40.33%

1 year+707.63%

YTD+44.32%

P/E-25.99

P/B2.28

P/S62.41

P/FCF-11.81

EPS-0.7400

Div yield—

ROE-8.78%

ROA-7.72%

Debt/Eq—

Current10.17

EV/EBITDA-8.50

Gross margin—

Net margin-240.13%

Rev growth1181.27%

EPS growth34.12%

Price target5.33

Target upside119.79%

Analyst ratingBuy

Institutional58.13%

Ent. value358.54M

Revenue0

Net income-16.99M

Gross profit—

Free cash flow-38.33M

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNasdaq

Shares out186.64M

Employees23

ListedFri, May 5, 2017

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction55 / 100

Pattern quality—

Tech rank71.9 / 100

Group rank50 / 100

Status lane—

Setup direction—

Pattern family

Resistance—

Support—

Days since event—

Candle confirmBullish engulfing

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in OVID

All disclosures →

No recent disclosed trades by Congress in OVID. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in OVID · 3 buys

Insider	Side	Shares	Value	Traded	Filed
Fitzgerald Kevin Joseph Director · Common Stock · 2026-04-07	Grant	17.58K	$45K	2026-04-07	2026-04-09
PAPADOPOULOS STELIOS Director · Common Stock · 2026-04-07	Grant	17.58K	$45K	2026-04-07	2026-04-09
Friedman Bart Director · Common Stock · 2026-04-07	Grant	8.79K	$22K	2026-04-07	2026-04-09

SEC filings

EDGAR filings in OVID · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.

Start free — 7-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.